Type 2 diabetes
Conditions
Interventions
None listed
Sponsors
Yokohama City University hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: <Type 2 diabetes group> Hospitalized Patients with type 2 diabetes who fulfilled the following criteria. 1) Age is over 20 and below 70. 2) Patients diagnosed with type 2 diabetes. 3) Having provided voluntary written consent for participation in this study. <Control group> Hospitalized Patients with nontype 2 diabetes who fulfilled the following criteria. 1) Age is over 20 and below 70. 2) Patients who are not diagnosed with type 2 diabetes. 3) Having provided voluntary written consent for participation in this study.
Exclusion criteria
Exclusion criteria: Patients corresponding to any of the following are inapplicable < Type 2 diabetes group> 1)Patients with severe complications( liver disease, mental disorder, cancer) 2)Patients with severe ketosis or diabetic coma. 3)Patients with severe infections, perioperative status, or severe trauma 4) Patients whose baseline eGFR wewre <29 ml/min/1.73m^2 5)Pregnancy or lactation in women 6) Patients who are judged by an investigator to be inappropriate for this study for any other reason. <Control group> 1)Patients with severe complications( liver disease, mental disorder, cancer) 2)Patients with severe infections, perioperative status, or severe trauma 3)Pregnancy or lactation in women 4) Patients who are judged by an investigator to be inappropriate for this study for any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum SerpinB1 level | — |
Secondary
| Measure | Time frame |
|---|---|
| The association of the serum SerpinB1 with the various metabolic parameters is analyzed in enrolled subjects. | — |
Countries
Japan
Contacts
Public ContactKazuki Tajima
Yokohama City University Graduate School of Medicine Department of Endocrinology and Metabolism
Outcome results
None listed